Glucagon-like peptide-1 receptor agonists (GLP-1 RA), also known as incretin mimetics, represent a class of prescription medications used to treat hyperglycemia in patients with type 2 diabetes mellitus and promote weight loss in obese patients [10]. This evidence concerns the gene GLP1R and diabetes mellitus.